Current Neuropharmacology

Papers
(The TQCC of Current Neuropharmacology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease252
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach127
Crosstalk between Inflammation and the BBB in Stroke77
Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke67
Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases66
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective61
A Scientometrics Analysis and Visualization of Depressive Disorder59
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled51
Alzheimer’s Disorder: Epigenetic Connection and Associated Risk Factors51
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition49
‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports47
Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia47
The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders46
The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke45
Selenium and Neurological Diseases: Focus on Peripheral Pain and TRP Channels44
Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease42
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications42
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress41
The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target38
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation38
PTSD in the COVID-19 Era36
Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury36
The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms34
Potential Mechanisms and Clinical Effectiveness of Acupuncture in Depression33
Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways32
Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review32
5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders31
The Role of Autophagy in the Pathogenesis of Ischemic Stroke31
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development31
A New Vision of Mitochondrial Unfolded Protein Response to the Sirtuin Family31
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease30
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease30
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease30
Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption after Subarachnoid Hemorrhage29
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases28
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia28
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System28
The Effects of General Anesthetics on Synaptic Transmission28
Depression and Pain: Use of Antidepressants28
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)27
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection27
Management Perspective of Wilson’s Disease: Early Diagnosis and Individualized Therapy27
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperact26
Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders26
Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease25
New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria25
Traumatic Brain Injury: A Forensic Approach: A Literature Review24
Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry23
The Links between Cardiovascular Diseases and Alzheimer's Disease23
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases23
An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants22
Acid-Sensing Ion Channels: Focus on Physiological and Some Pathological Roles in the Brain22
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor22
Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury21
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders21
Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine21
Neurodegenerative Pathways in Alzheimer’s Disease: A Review20
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease20
Neural Substrates for the Regulation of Sleep and General Anesthesia20
SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan19
Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases19
Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences19
The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies19
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update19
Emerging Evidence for Neuropsycho-Consequences of COVID-1919
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy19
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer’s Disease18
Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease18
Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation18
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease18
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review18
Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease18
Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression18
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy17
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention17
Association of Oxidative Stress with Neurological Disorders17
Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link17
Tyrosol as a Neuroprotector: Strong Effects of a “Weak” Antioxidant17
Circadian Rhythm Disruption and Alzheimer’s Disease: The Dynamics of a Vicious Cycle17
From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod17
Effects of General Anesthetics on Synaptic Transmission and Plasticity17
MicroRNAs in the Blood-Brain Barrier in Hypoxic-Ischemic Brain Injury17
The Dawn of Mitophagy: What Do We Know by Now?17
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy16
Xenogeneic Decellularized Extracellular Matrix-based Biomaterials For Peripheral Nerve Repair and Regeneration16
Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk16
Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment16
Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis16
A Comprehensive Review of Alzheimer’s Association with Related Proteins: Pathological Role and Therapeutic Significance16
Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives16
Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches16
Nerve Growth Factor in Alcohol Use Disorders16
Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights15
Chlorogenic Acid Improves PTSD-like Symptoms and Associated Mechanisms15
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment15
Adolescent Substance Abuse, Transgenerational Consequences and Epigenetics15
The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic Cannabinoids’ Information Available Online15
Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation15
Effects of Histone Modification in Major Depressive Disorder15
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-1915
Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain14
The Brain-gut Axis-where are we now and how can we Modulate these Connections?14
Is It the Twilight of BACE1 Inhibitors?14
Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice14
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors14
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art14
Targeting Glioblastoma: The Current State of Different Therapeutic Approaches14
Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update14
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases14
Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease14
Role of Grina/Nmdara1 in the Central Nervous System Diseases14
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmac14
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations14
Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review13
Effects of Di-2-Ethylhexyl Phthalate on Central Nervous System Functions: A Narrative Review13
Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder13
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases13
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects13
Novel Synthetic and Natural Therapies for Traumatic Brain Injury13
Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders13
Neurochemical and Behavioral Consequences of Ethanol and/or Caffeine Exposure: Effects in Zebrafish and Rodents13
Immune Checkpoint Inhibitors and Neurotoxicity13
Pharmacologic Treatment of Restless Legs Syndrome13
The Emerging Role of the Double-Edged Impact of Arachidonic Acid- Derived Eicosanoids in the Neuroinflammatory Background of Depression.13
BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors12
Protective Effects of Dendrobium nobile Lindl. Alkaloids on Alzheimer's Disease-like Symptoms Induced by High-methionine Diet12
Crocus Sativus L. (Saffron) in Alzheimer’s Disease Treatment: Bioactive Effects on Cognitive Impairment12
Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools12
Green Tea, A Medicinal Food with Promising Neurological Benefits12
The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases12
Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications12
Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation12
Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis12
The Complexity of Secondary Cascade Consequent to Traumatic Brain Injury: Pathobiology and Potential Treatments12
Evaluation of Anti-inflammatory Nutraceuticals in LPS-induced Mouse Neuroinflammation Model: An Update12
Current and Emerging Treatments for Methamphetamine Use Disorder12
Hydrogen Sulfide (H2S) Signaling as a Protective Mechanism against Endogenous and Exogenous Neurotoxicants12
Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?11
Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update11
Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders11
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study11
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease11
Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli11
Pathways Involved in Remyelination after Cerebral Ischemia11
Effects of Mulberry on The Central Nervous System: A Literature Review11
Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation11
Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach11
The Investigation into Neurotoxicity Mechanisms of Nonylphenol: A Narrative Review10
Crosstalk between Microglia and Neurons in Neurotrauma: An Overview of the Underlying Mechanisms10
C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside10
Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance10
Voxel-wise Functional Connectivity of the Default Mode Network in Epilepsies: A Systematic Review and Meta-Analysis10
Sceletium for Managing Anxiety, Depression and Cognitive Impairment: A Traditional Herbal Medicine in Modern-Day Regulatory Systems10
Early Biomarkers and Intervention Programs for the Infant Exposed to Prenatal Stress10
Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer’s Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review10
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?10
Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review10
Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports10
Melatonin as a Chronobiotic with Sleep-promoting Properties10
Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives10
Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy10
Treatment of Circadian Rhythm Sleep–Wake Disorders10
Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease10
Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review10
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases10
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance10
Identifying c-fos Expression as a Strategy to Investigate the Actions of General Anesthetics on the Central Nervous System9
Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources9
What About Drug Checking? Systematic Review and Netnographic Analysis of Social Media9
The Benzydamine Experience: A Systematic Review of Benzydamine Abuse9
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease9
Protective Effects of Polydatin Against Dementia-Related Disorders9
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis9
The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review9
Dapsone, More than an Effective Neuro and Cytoprotective Drug9
How to Optimize the Effectiveness and Safety of Parkinson’s Disease Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary Supplements9
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease9
The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review9
Putative Roles of Astrocytes in General Anesthesia9
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review9
Pharmacological Effects of Saffron and its Constituents in Ocular Disorders from in vitro Studies to Clinical Trials: A Systematic Review9
The Role of Astrogliosis in Formation of the Syrinx in Spinal Cord Injury9
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease9
Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas9
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study9
Cholinergic Modulation of General Anesthesia9
0.05233907699585